CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Activity

59 hedge funds and large institutions have $46M invested in CASI Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 20 closing their positions.

Holders
59
Holders Change
-10
Holders Change %
-14.49%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
14
Reduced
18
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$869K
2
Marshall Wace
2
Marshall Wace
United Kingdom
$1.13M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.12M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$276K
5
CSS
5
Cubist Systematic Strategies
Connecticut
$260K

Top Sellers

1
CCM
1
Consonance Capital Management
New York
$1.86M
2
Charles Schwab
2
Charles Schwab
California
$65K
3
Millennium Management
3
Millennium Management
New York
$969K
4
TEE
4
Tibra Equities Europe
United Kingdom
$0
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$8K
Name Market Value Shares Shares
Change 		Shares
Change %
QCG
76
Quadrant Capital Group
Ohio
– – -266 Closed
FF
77
FourThought Financial
Florida
– – -40 Closed
Northwestern Mutual Wealth Management
78
Northwestern Mutual Wealth Management
Wisconsin
$0 132 – –
JPLA
79
Joseph P. Lucia & Associates
New York
$0 1 – –
CFGS
80
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4